Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Functional Connectivity at Rest and During Cognitive Processing in Multiple Sclerosis: A Pilot Magnetoencephalography Study and Systematic Review.
Journal: Brain sciences
Published: June 03, 2026
Longitudinal and Stability-Aware Analysis Reveals Treatment-Specific MicroRNA Response Signatures Following Immune-Reconstitution and B-Cell-Targeted Therapies in Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: April 07, 2026
Multiple sclerosis in the All of Us Research Program: Prevalence and associated demographic and geographic characteristics.
Journal: Multiple sclerosis and related disorders
Published: July 31, 2025
Corrigendum to "Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics data" [Multiple Sclerosis and Related Disorders Volume 92, December 2024, 105942].
Journal: Multiple sclerosis and related disorders
Published: May 06, 2025
A Comprehensive Characterization of Patients with Spinal Cord Neurosarcoidosis: A Single Center Cross-Sectional Study of Clinical Outcomes.
Journal: Journal of clinical medicine
Published: July 24, 2024
Maresin-1 promotes neuroprotection and modulates metabolic and inflammatory responses in disease-associated cell types in preclinical models of multiple sclerosis.
Journal: The Journal of biological chemistry
Published: July 23, 2024
Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple Sclerosis.
Journal: Metabolites
Published: July 13, 2024
Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics data.
Journal: Multiple sclerosis and related disorders
Published: June 20, 2024
Current understanding of cardiovascular autonomic dysfunction in multiple sclerosis.
Journal: Heliyon
Published: May 30, 2024
Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosis.
Journal: bioRxiv : the preprint server for biology
Published: February 19, 2024
Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patients.
Journal: bioRxiv : the preprint server for biology
Published: January 23, 2024
Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell types.
Journal: bioRxiv : the preprint server for biology
Published: October 09, 2023
Last Updated: 09/26/2026